|
18 documents found matching cs:norvir*.
|
|
of 2
Prev
Next
|
|
|
|
Showing 1-10 of 18 documents
|
1.
Deposition of Douglas F Greer
|
Document Date:
|
20071214
|
|
Author:
|
Greer, Douglas
|
|
Search Terms in Context:
|
EXHIBIT 49
pgNbr=1
DOUGLAS F. GREER, PH.D.
12/14/07
Page 1
1 UNITED STATES DISTRICT COURT
2 NORTHERN DISTRICT OF CALIFORNIA 3
4 IN RE ABBOTT LABORATORIES Case No.
NORVIR ANTITRUST LITIGATION C-04-1511 CW
5
6
7
8
9 10 11
12 _______________________:____;______________________
13
14 DEPOSITION OF DOUGLAS F. GREER, Ph.D.
15 Friday, December 14, 2007
16 San Francisco, California 17
18 19 20
21 Reported by: EMI ALBRIGHT
22 RPR, CSR No. 13042
23 Job No. 78779 24
25
SARNOFF COURT REPORTERS AND LEGAL TECHNOLOGIES 877.955.3855
pgNbr=2
DOUGLAS F. GREER, PH.D. 12/14/07
Page 196
1 other because of all the elements that go into that. So
2 that all you can say is the incentive is likely to have
3 been lessened.
4 It's kind of like what I was talking abo
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/oxx19k10
|
|
| |
2.
[Price Increase: 3 Options]
|
Document Date:
|
20031209
|
|
Author:
|
Leal, Jesus
|
|
Search Terms in Context:
|
EXHIBIT 18
pgNbr=1
¦^
Jesus Leal To: Laureen M Cassidy/LAKE/PPD/ABBOTT@ABBOTT
09/Ì2/2003 09:03 AM Subject: Pricing/capsule withdrawal
Laureen,
As promised below are some more thoughts to help you with the messaging. Please don't be stunned by the outcome of the thought process because although it is a continuation of yetserday's conversation, the conclusion is quite different. What I have tried to do is to outline a stratight forward startegy, the elements of the announcement without intertwining a convoluted story that won't hold up to scrutiny by the press or the public and identify glaring weaknesses.
Option 1: Price Increase A
Strategy: One price policy for Abbott protease inhibitors
Announce free/reduced cost Norvir liquid for patients on Norvir as of October 31st.
Announce price increase of Norvir capsules for all new patients to the price of daily Kaletra. Offer patiets the choice to continue taking the capsules at the new price.
Announce that Norvir dosin
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/oxx19a10
|
|
| |
3.
Declaration of Michael Hannan
|
Document Date:
|
20030324
|
|
Author:
|
Hannan, Michael
|
|
Search Terms in Context:
|
EXHIBIT 47
pgNbr=1
Joseph J. Tabacco, Jr. (75484) Christopher T. Heffelfinger (118058) BERMAN DEVALERIO PEASE TABACCO BURT&PUCILLO
425 California Street, Suite 2100
San Francisco, CA 94104 ^e^ßS!?En
Telephone: (415)433-3200 HctESVElJ
Facsimile: (415)433-6382
Fil i 0 2006 Richard R. Wiebe (121156)
LAW OFFICE OF RICHARD R. WIEBEMf M'Ä'luw 425 California Street, Suite 2025 hSM Hi W »LlA
San Francisco, CA 94104 BAKtANö
Telephone: (415) 433-3200
Counsel for Plaintiffs John Doe 1 and John Doe 2
Hollis Salzman (HS-5994)
Michael W. Stocker (179083)
Bernard Persky (BP-1072)
LABATON RUDOFF & SUCHAROW LLP
100 Park Avenue New York, NY 10017 Telephone: (212) 907-0700 Facsimile: (212)818-0477
Counsel for Plaintiff Service Employees International Union Health and Welfare Fund
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA
IN RE ABBOTT LABS NORVIR ANTITRUST LITIGATION
No. C-04-1511CW
DECLARATION OF MICHAEL P. HANNAN
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/oxx19j10
|
|
| |
4.
[e-mail re slide list]
|
Document Date:
|
20030929
|
|
Author:
|
Leal, Jesus
|
|
Search Terms in Context:
|
EXHIBIT 39
pgNbr=1
Jesus Leal
09/29/2003 07:58 PM
To: Carlos A Carlos/LAKE/PPD/ABBOTT@ABBOTT, Jeffrey J Devlin/LAKE/PPD/ABBOTT@ABBOTT Subject: Mile White presentation
Hi gentlemen, Below are some thoughts for the slide set (please note - slide set - not slide deck)
I would strongly suggest that you use graphs, pictures etc to help you get a few key points accross. If you send me your work in progress, I can help from nancy's office tomorrow afternoon.
I hope this helps.
Slide #
message from the slide
What's on the slide
Slide 1
Market share slide (whichever one shows the most dramatic impact of Rayataz's launch)
Kaletra share down Rayataz share up Norvir share up
Slide 2
Slide showing decrease in Norvir capsules/day
Norvir pill count/day decreasing trending to 1 tab/day by year's end, a 92% reduction from the approved dose
Slide 3
Market research slide showing % of MDs that will use unboosted Rayatz versus boost Rayataz
Rayataz would not add much value to the treatment of a HIV patient with
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/oxx19h10
|
|
| |
5.
[e-mail PR story on BMS Reyataz]
|
Document Date:
|
20030717
|
|
Author:
|
Mason, Heather
|
|
Search Terms in Context:
|
EXHIBIT 20
pgNbr=1
***** M-Jl
Heather L Mason
¡F¿:¿í' 07/17/2003 07:43 PM
To: Jeffrey J Devlin/LAKE/PPD/ABBOTT@ABBOTT, Jaek Rivetti/LAKE/PPD/ABBOTT@ABBOTT, Nancy C Coseo/LAKE/PPD/ABBOTT@ABBOTT Subject: See Attached ASAP
One concept I'd like to make sure we have in reps heads is the veracity of BMS' claim that 045 patients are highly treatment experienced. If I remember correctly, patients failed two regimens, but not necessarily PI based regimens. Just a thought you have most likely had! Thx. Heather
-.— Forwarded by Heather L Mason/LAKE/PPD/ABBOTT on 07/17/2003 06:41 PM -—
'<°™*Yrr****' Michelle M Jones
07/15/2003 09:30 AM
To: Laureen M Cassidy/LAKE/PPD/ABBOTT@ABBOTT, William G Dempsey/LAKE/PPD/ABBOTT@ABBOTT, Jerald J Wenker/LAKE/GPRD/ABBOTT@ABBOTT, Heather L Mason/LAKE/PPD/ABBOTT@ABBOTT, Jodl L Devlin/LAKE/PPD/ABBOTT@ABBOTT, Laura J Schumacher/LAKE/CORP/ABBOTT@ABBOTT cc: Melissa D Brotz/LAKE/PPD/ABBOTT@ABBOTT Subject: See Attached ASAP
Good Morning,
Melissa asked that I send this out to
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/oxx19b10
|
|
| |
6.
Rebuttal Expert Report of Joel W. Hay, Ph.D.
|
Document Date:
|
20071031
|
|
Author:
|
Hay, Joel
|
|
Search Terms in Context:
|
EXHIBIT 1
pgNbr=1
Nicole M. Norris (SBN 222785)
James F. Hurst (Admitted Pro Hac Vice)
David J. Doyle (Admitted Pro Hac Vice)
Samuel S. Park (Admitted Pro Hac Vice)
WINSTON & STPvAWN LLP
101 California Street, Suite 3900
San Francisco, CA 94111-5894
Telephone: 415-591-1000
Facsimile: 415-591-1400
Email: nnorris@winston.com; jhurst@winston.com;
ddoyle@winston.com; spark@winston.com
Attorneys for Defendant ABBOTT LABORATORIES
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
OAKLAND DIVISION
IN RE ABBOTT LABS NORVIR ANTITRUST LITIGATION
CaseNo.C-04-1511CW
REBUTTAL EXPERT REPORT OF JOEL W. HAY, PH.D.
HIGHLY CONFIDENTIAL
1
Rebuttal Expert Report of Joel W. Hay, Ph.D.
pgNbr=2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Highly Confidential Pursuant to Protective Order
Also in contrast to a tying arrangement, there are more sales of the stand alone product, Norvir, than of the bundled product, Kaletra. In Septembe
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/oxx18w10
|
|
| |
7.
Deposition of Heather Mason, Day 2
|
Document Date:
|
20040910
|
|
Author:
|
Mason, Heather
|
|
Search Terms in Context:
|
EXHIBIT 27
pgNbr=1
9/10/2004 Mason, Heather Day 2
STATE OF ILLINOIS
3 4 5
COUNTY OF COOK
IN RE:
) SS:
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
NORVIR )
The continued subpoenaed deposition of HEATHER MASON, taken before MARIA MAZZA, CSR, Notary Public, pursuant to the provisions of the Code of Civil Procedure of the State of Illinois and the Rules of the Supreme Court thereof pertaining to the taking of depositions for the purpose of discovery at the law offices of Winston & Strawn, LLP, 35 West Wacker Drive, Chicago, Illinois, commencing at 9:20 o'clock a.m., on the 10th day of September, A.D., 2004.
Highly Confidential Attorneys' Eyes Only
205 NOR 00095213
pgNbr=2
9/10/2004 Mason, Heather Day 2
¦V
1 so those are the two dynamics.
2 Q If you can turn to the document you have
3 before you, if you can turn to Page 16192.
4 A Yes.
5 Q If we could look at the first row, the second
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/oxx19c10
|
|
| |
8.
HIV Market Research Monthly Report, January 2006
|
Document Date:
|
20060101
|
|
Author:
|
Rahn, Laurie|Serio, Joe|Emirch, Katherine|Freund, Amie
|
|
Search Terms in Context:
|
EXHIBIT 45
pgNbr=1
HIV Market Research Monthly Report:
January, 2006 (December Data)
Developed by:
¦ Laurie Rahn
¦ Joe Serio
¦ Katherine Emrich
¦ Amie Freund
Market Research & Business Intelligence f—J Abbott
A Promise for Life
NOR 104545 HIGHLY CONFIDENTIAL ATTORNEY EYES ONLY
pgNbr=2
Table of Contents
Dashboard Summary 3
Net Sales vs. Plan/Update 4
Kaletra TRx Performance vs. Plan/Update 5-6
Competitor TRx Share vs. Plan/Update 7
ARV Anchor Market Metrics 8-17
Norvir Market Metrics 18-21
Appendix 22-24
NOR 104546 HIGHLY CONFIDENTIAL ATTORNEY
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/oxx19i10
|
|
| |
9.
Deposition of John Leonard
|
Document Date:
|
20070724
|
|
Author:
|
Leonard, John
|
|
Search Terms in Context:
|
EXHIBIT 51
pgNbr=1
Page 1 1
2 UNITED STATES DISTRICT COURT
3 NORTHERN DISTRICT OF CALIFORNIA 4
5 IN RE:
6 ABBOTT LABORATORIES
7 ANTITRUST LITIGATION
8 ____________________
9
10
11
12 HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY
13
14 DEPOSITION OF JOHN LEONARD, M.D.
15 July 24, 2007
16 Chicago, Illinois 17 18
19 Reported by:
20 KELLY M. FITZGERALD, CSR, RMR, CRR
21 JOB NO. 12509 22 23 24 25
) ) ) C-04-1511 CW
)
TSG Reporting - Worldwide 877-702-9580
pgNbr=2
Pagello
1 HIGHLY CONFIDENTIAL - LEONARD
2 bioequivalent and stable, these are projections
3 that are meaningless.
4 Q. Is there a difference between the
5 second generation Kaletra Meltrex and the
6 Kaletra Meltrex that's currently on the market?
7 A. Well, the objectives are different.
8 Well, the objectives are related in a sense
9 that we've tried very hard since the Kaletra
10 work be
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/oxx19m10
|
|
| |
10.
Deposition of Jesus Leal
|
Document Date:
|
20040809
|
|
Author:
|
Leal, Jesus
|
|
Search Terms in Context:
|
EXHIBIT 4
pgNbr=1
8/9/2004 Jesus Leal
1 STATE OF ILLINOIS )
2 ) SS.
3 COUNTY OF COOK ) 4
5 6
7 IN RE: )
8 )
9 NORVIR ) 10
11 12
13 The deposition of JESUS LEAL, taken
14 before Kathleen P. Lipinski, Certified Shorthand
15 Reporter and Notary Public, taken pursuant to
16 the provisions of the Illinois Code of Civil
17 Procedure and the Rules of the Supreme Court
18 thereof pertaining to the taking of depositions
19 for the purpose of discovery at 35 West Wacker
20 Drive, 35th Floor, Chicago, Illinois, commencing
21 at 9:30 o'clock a.m. on the 9th day of August,
22 A.D., 2004. 23
24
Highly Confidential Attorneys' Eyes Only
NOR 00093236
pgNbr=2
8/9/2004 Jesus Leal
1 October of 2003?
2 A. Did Lexiva come out --
|
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/oxx18x10
|
|
| |
|
Prev
Next
|
